Clinical trials to evaluate the efficacy of Dashang Agad in Dengue Fever.

Randomised controlled clinical trials to evaluate the efficacy of Dashang Agad in the management of Dengue Fever w.s.r.to Thrombocytopenia and Leucopenia. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083451

Enrollment

Registered

2025-03-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A90- Dengue fever [classical dengue]

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient of age from 18yrs to 60 yrs 2.Patient Who gives written informed consent 3.Patient of either sex 4.Diagnosed cases of Dengue fever 5.Patient irrespective of cast religion economic status

Exclusion criteria

Exclusion criteria: 1.Patients of HIV HBsAg positive 2.Patients of Dengue with uncontrolled DM HTN Kochs any systemic diseases 3.Patients of DHF and DSS 4.Patients having platelet count below 50,000 5.patients not willing for trial 6.pregnant females and lactating mothers.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Dashang agad in Dengue feverTimepoint: On 1st,3rd,7th,15th day of trial.	—

Secondary

Measure	Time frame
1.To study Ayurvedic and modern literature regarding Dengue fever. 2.To minimize the side effects of modern medicine 3.To minimize the complications of Dengue feverTimepoint: On 1st,3rd,7th,15th day of trial.	—

Countries

India

Contacts

Public ContactDr N S Gangasagre

Government Ayurvedic College and Hospital Dharashiv

gacosbd@gmail.com9422165970

Outcome results